Exos TFP Holdings’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Exos TFP Holdings’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,726	Closed	-$59.7K	–	477
2023 Q1	$59.7K	Hold	5,726	–	–	0.02%	300
2022 Q4	$58.3K	Buy	+5,726	New	+$58K	0.02%	321

Exos TFP Holdings's LVAC Position: Q2 2023 in Review

Exos TFP Holdings sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 5,726 shares — an estimated $59.7K sold.

Exos TFP Holdings first reported a position in LVAC in Q4 2022 and held it in 2 quarters. The position peaked at $59.7K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Exos TFP Holdings reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Exos TFP Holdings sold 5,726 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $59.7K.
Exos TFP Holdings first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 2 quarters.
Exos TFP Holdings's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $59.7K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Exos TFP Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.